ADA issues first online updates to Standards of Care

Access to the full content of this site is available only to registered healthcare professionals. Access to the full content of this site is available only to registered healthcare professionals.

Takeaway

  • New information about hypoglycemia and medications for type 2 diabetes are the first online revisions to the American Diabetes Association’s (ADA's) Standards of Medical Care in Diabetes, which were previously only updated annually.

Why this matters

  • The diabetes field advances rapidly.

2 new updates to 2018 ADA Standards

  • A revised definition of hypoglycemia in sections 6 and 14: both sections on glycemic targets and on diabetes care in the hospital have been updated to align with the new 3-level hypoglycemia categorization from a consensus report of ADA and other diabetes-related organizations, published in December 2017 in Diabetes Care.
  • 2 new drugs added to section 8: the glucagon-like peptide-1 agonist semaglutide (Ozempic) and the sodium-glucose cotransporter 2 inhibitor ertugliflozin (Steglatro) have been added to the section on pharmacologic approaches to glycemic treatment, after their approval by the FDA in December 2017.